World Of Taxonomy
69604-204Level 3

Anthim (obiltoxaximab)

**Product type:** Human Prescription Drug

**Active ingredient:** OBILTOXAXIMAB

**Strength:** 100 mg/mL

**Dosage form:** Solution

**Route:** Intravenous

**Labeler:** Elusys Therapeutics, Inc.

**Marketing category:** BLA (BLA125509)

**Pharmacologic class:** Anthrax Protective Antigen-directed Antibody Interactions [MoA], Anthrax Protective Antigen-directed Antibody [EPC]

GET/api/v1/systems/ndc_fda/nodes/69604-204
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.